COMPARISON OF THE EFFECTIVENESS OF TRIGLYCERIDE REDUCTION USING PLASMA EXCHANGE THERAPY AND INSULIN THERAPY IN THE TREATMENT OF PATIENTS WITH ACUTE PANCREASITIS
Main Article Content
Abstract
Objective: "Compare the effectiveness of triglyceride reduction by plasma exchange therapy and insulin therapy in the treatment of patients with acute pancreatitis". Subjects and Methods: Includes 30 AP patients with hyperglycemia treated with Insulin and TPE therapy at Thai Nguyen Nation Hospital from June 2022 to March 2024. Results: Both 2 groups have 3 patients developed severe AP. TG decreased <10 mmol/L after 24 hours of admission. TG decreased more within 24 hours after admission in the TPE group (66 ± 15%) compared to the Insulin group (55 ± 18%), p > 0.05. Cholesterol levels were also lower after 24 hours of hospitalization in the TPE group. TG decreased < 10 mmol/L on average after 1 day in the TPE group and after 2 days in the Insulin group. Both 2 groups had 3 cases of severe AP. Hospital stay was similar in both 2 groups, and survival rates were both 100%. There was one case of mild hypoglycemia in the Insulin group and some urticaria and hypotension in the TPE group. Conclusion: There is no difference in the effectiveness of TG reduction with TPE therapy and Insulin therapy in the treatment of patients with acute pancreatitis
Article Details
Keywords
effectiveness, triglycerides, plasma exchange therapy, Insulin therapy, treatment, acute pancreatitis
References
2. Araz F, Bakiner OS, Bagir GS, et al. Continuous insulin therapy versus apheresis in patients with hypertriglyceridemia-associated pancreatitis. Eur J Gastroenterol Hepatol.Ther Apher Dial. (2021) 25:681–6. doi: 10.1111/1744-9987.13603
3. Chen Z, Huang X, Zhang M, et al. Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis. J Clin Apher. (2022) 37:82–90. doi: 10.1002/jca.21954
4. Dichtwald S, Meyer A, Zohar E, et al. Hypertriglyceridemia induced pancreatitis: plasmapheresis or conservative management? J Intensive Care Med. (2021) (in press). doi: 10.1177/08850666211054365
5. Gubensek J, Buturovic-Ponikvar J, Marn-Pernat A, et al. Treatment of hyperlipidemic acute pancreatitis with plasma exchange: a single-center experience. Ther Apher Dial. (2009) 13:314–7. doi: 10.1111/j. 1744-9987. 2009.00731.x
6. Gubensek J, Buturovic-Ponikvar J, Romozi K, Ponikvar R. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study. PLoS One. (2014) 9:e102748. doi: 10.1371/journal.pone.0102748
7. Lu Z, Chen Y, Wu Y, et al. The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: a propensity score matching analysis. J Clin Apher. (2020) 35:388–97. doi: 10.1002/jca. 21811
8. Miyamoto K, Horibe M, Sanui M, et al. Plasmapheresis therapy has no triglyceride-lowering effect in patients with hypertriglyceridemic pancreatitis. Intensive Care Med. (2017) 43:949–51. doi: 10.1007/s00134-017-4722-3